Form 4/A for CRL Charles River Laboratories
Accepted 2024-05-30 00:00:00 ET · period of report 2024-05-26 · accession 0001127602-24-017055 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2024-05-30 | 2024-05-26+ | CRL | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $217.21 | -406 | 7,795 | -5% | -$88.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-27 | F | D | 194 | $217.21 | 7,601 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-26 | F | D | 212 | $217.21 | 7,795 | D | — | — |